Since my first coverage on Omega Healthcare Investors, Inc. ( OHI ), where I rated them a Buy, the stock is up about 13%, with several events worth taking into account.As of 2025, I've got over 10 years of researching companies. In total, throughout my investing life, I estimate that I researched (in depth) well over 1000 companies, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emerging market stocks, which I believe could help me provide useful content for re ...

Since my first coverage on Omega Healthcare Investors, Inc. ( OHI ), where I rated them a Buy, the stock is up about 13%, with several events worth taking into account.As of 2025, I've got over 10 years of researching companies. In total, throughout my investing life, I estimate that I researched (in depth) well over 1000 companies, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emerging market stocks, which I believe could help me provide useful content for re ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Industry Overview - The global population is aging rapidly, with the number of individuals aged 60 and above surpassing those under five for the first time in 2020, leading to significant implications for healthcare systems and investors [2] - By 2050, nearly 22% of the global population will be over 60, with a significant concentration in low- and middle-income countries [2] - The geriatric care services industry is currently valued at approximately $1.21 trillion and is projected to grow to around $2.12 trillion by 2034, reflecting a compound annual growth rate (CAGR) of 6.4% [3] Market Dynamics - Evolving healthcare utilization patterns due to aging are creating growth opportunities in senior living communities, skilled nursing facilities, assisted living, and post-acute care providers [4] - The Centers for Medicare & Medicaid Services (CMS) has advanced the Program of All-Inclusive Care for the Elderly (PACE), aimed at providing comprehensive care for seniors [4] Key Players - Major healthcare companies like Boston Scientific, AbbVie, Amgen, and Edwards Lifesciences are actively expanding their presence in the senior and aging demographics [5] - The Ensign Group is expanding its skilled nursing and rehabilitative services, supported by a decentralized management strategy [7] - Healthcare real estate investment trusts (REITs) such as Omega Healthcare Investors and CareTrust REIT are focusing on skilled nursing and senior housing properties [7] Investment Perspective - The senior-care services sector is resilient during economic downturns, providing stable cash flows and making it attractive for long-term investors seeking defensive growth [8] Company Highlights - **Boston Scientific**: Focuses on medical devices for the elderly, including the WATCHMAN device for stroke risk reduction and the SYNERGY bioabsorbable stent system [9][10] - **AbbVie**: Expanding its focus on the aging demographic through strategic partnerships, including the acquisition of Aliada Therapeutics for Alzheimer's treatment [11][12][14] - **Amgen**: Targeting the aging population with innovations in biopharma, including obesity treatments and bone health therapies [15][16] - **Edwards Lifesciences**: Advancing care for aortic stenosis in elderly patients, with significant sales growth in structural-heart solutions [17][18][19]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q3 2025 were $0.79 per share, with funds available for distribution (FAD) at $0.75 per share, reflecting strong revenue and EBITDA growth driven by acquisitions and active portfolio management [4][25] - The dividend payout ratio decreased to 85% for AFFO and 89% for FAD, indicating improved financial health [4] - The 2025 AFFO guidance was raised to a range of $3.08 to $3.10 per share, representing an 8% year-over-year growth compared to 2024 AFFO of $2.87 per share [4][29] Business Line Data and Key Metrics Changes - The core portfolio consists of 1,024 facilities, with 60% being skilled nursing facilities and transitional care facilities in the U.S. and 40% in U.S. senior housing and UK care homes [13] - Trailing 12-month operator EBITDA coverage for the core portfolio increased to 1.55 times, up from 1.51 times in Q1 2025, indicating improved financial stability among operators [13][14] Market Data and Key Metrics Changes - Omega Healthcare Investors completed over $978 million in new investments through October 2025, with $850 million (87%) allocated to real estate investments [17] - The company reported $151 million in new investments during Q3 2025, including $67 million in real estate acquisitions and $84 million in real estate loans [18] Company Strategy and Development Direction - The company aims to enhance shareholder value by allocating capital primarily to healthcare real estate, focusing on growing FAD per share on a risk-adjusted basis [6][12] - Omega is expanding investment structures to align with operators, including joint ventures and minority interest investments, to achieve higher returns over time [7][10] - The company is evaluating RIDEA structures in both the U.S. and U.K. to enhance investment flexibility [11][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth of the eldercare industry, anticipating substantial market opportunities in both the U.S. and U.K. [23] - The company is monitoring potential impacts from Medicare cuts and state budget allocations but remains optimistic due to strong fundamentals and demographic trends [33][34][76] Other Important Information - Omega's balance sheet remains strong, with $737 million in cash and a fixed charge coverage ratio of 5.1 times [27][28] - The company has entered into a new $2.3 billion credit facility to improve liquidity and capital structure [27] Q&A Session Summary Question: Details on pursuit of higher growth shop or RIDEA opportunities - Management indicated that investment volumes will depend on available opportunities and emphasized a focus on long-term value creation [38][40] Question: Future dividend growth potential - The board is considering a pathway for dividend increases, with a focus on maintaining a balance between dividends and capital for growth [42] Question: SABR portfolio coverage and occupancy trends - Coverage for the SABR portfolio is trending above 1.46 times, with occupancy in the low 90% range [44][45] Question: Strategy behind lower yield for OPCO investment - Management highlighted that the projected cash flow from the OPCO investment is expected to yield high returns over time, despite a lower initial yield [53][55] Question: Labor availability issues in the U.S. versus the U.K. - Wage increases are matching inflation, with the U.K. facing fewer staffing issues compared to the U.S. [62] Question: Medicaid cuts and state budget concerns - Management is monitoring state budgets but remains confident in the company's positioning and coverage levels [76][77]

Omega Healthcare Investors (OHI) reported $311.59 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 12.9%. EPS of $0.79 for the same period compares to $0.42 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $308.6 million, representing a surprise of +0.97%. The company delivered an EPS surprise of +2.6%, with the consensus EPS estimate being $0.77.While investors closely watch year-over-year changes in headline numbers -- revenue an ...

Core Insights - Omega Healthcare Investors (OHI) reported quarterly funds from operations (FFO) of $0.79 per share, exceeding the Zacks Consensus Estimate of $0.77 per share and up from $0.74 per share a year ago [1][2] - The company achieved an FFO surprise of +2.60% for the quarter, having surpassed consensus FFO estimates three times over the last four quarters [2] - Revenues for the quarter ended September 2025 were $311.59 million, surpassing the Zacks Consensus Estimate by 0.97% and up from $276.03 million year-over-year [3] Financial Performance - The FFO for the previous quarter was $0.77, which also beat the expected $0.75, resulting in a surprise of +2.67% [2] - The current consensus FFO estimate for the upcoming quarter is $0.78, with projected revenues of $310.44 million, and for the current fiscal year, the estimate is $3.07 on $1.18 billion in revenues [8] Market Position - Omega Healthcare Investors has underperformed the market with a gain of about 4.4% since the beginning of the year, compared to the S&P 500's gain of 17.2% [4] - The Zacks Industry Rank places the REIT and Equity Trust - Other sector in the top 34% of over 250 Zacks industries, indicating a favorable industry outlook [9] Future Outlook - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and future FFO expectations [4] - The estimate revisions trend for Omega Healthcare Investors was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it will perform in line with the market [7]

Exhibit 99.1 303 International Circle P: 410.427.1700 Suite 200 Hunt Valley, MD 21030 PRESS RELEASE – FOR IMMEDIATE RELEASE OMEGA REPORTS THIRD QUARTER 2025 RESULTS AND RECENT DEVELOPMENTS Completed $978 Million in New Investments Year-to-Date Closed a New $2.3 Billion Unsecured Credit Facility Increased Full Year Adjusted FFO Guidance Repaid $600 Million of Senior Unsecured Notes in Q4 HUNT VALLEY, MARYLAND – October 30, 2025 – Omega Healthcare Investors, Inc. (NYSE: OHI) (the "Company" or "Omega") announc ...

Core Viewpoint - The article discusses three high-yield healthcare stocks: Kenvue, Pfizer, and Omega Healthcare, emphasizing the importance of understanding the underlying business and risks associated with high dividend yields [2][15]. Kenvue - Kenvue, spun off from Johnson & Johnson in mid-2023, primarily sells over-the-counter products and is more akin to a consumer staples company [3][5]. - The stock has faced challenges, with a 4% decline in sales and a drop in adjusted earnings from $0.32 to $0.29 per share year-over-year [5]. - The current dividend yield is notably high at 5.5%, compared to the average consumer staples yield of 2.7% [6]. - The stock price has fallen significantly, leading to increased yield, but it lacks a strong dividend track record [6]. Pfizer - Pfizer is a well-established pharmaceutical company with a current dividend yield of 6.9% [8][11]. - The company is addressing industry challenges by making capital investments and acquiring Metsera to enhance its drug pipeline [9]. - Pfizer's dividend payout ratio is around 90%, raising concerns about potential cuts, especially following its acquisition of Metsera [11]. - The stock has decreased nearly 60% since late 2021, positioning it as a potential turnaround story [11]. Omega Healthcare - Omega Healthcare is a senior-housing-focused REIT with an attractive dividend yield of 6.6% [12][14]. - The company successfully maintained its dividend during the COVID-19 pandemic, unlike many peers who cut dividends [13]. - Omega is now acquiring assets and returning to normal operations, making it a relatively stable investment choice in the senior housing sector [14][15].